Suppr超能文献

[已撤回] miR-663通过直接靶向CDKN2A促进鼻咽癌细胞增殖。

[Retracted] miR‑663 promotes NPC cell proliferation by directly targeting CDKN2A.

作者信息

Liang Shaoqiang, Zhang Ning, Deng Yanming, Chen Lusi, Zhang Yang, Zheng Zhenhe, Luo Weijun, Lv Zhiqian, Li Shaoen, Xu Tao

机构信息

Department of Radiotherapy, Tumor Hospital of First People's Hospital of Foshan, Foshan, Guangdong 528041, P.R. China.

出版信息

Mol Med Rep. 2022 Jan;25(1). doi: 10.3892/mmr.2021.12539. Epub 2021 Nov 23.

Abstract

Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that certain of the cell cycle assay data shown in Figs. 2D and 5C were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to , the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [the original article was published in 16: 4863‑4870, 2017; DOI: 10.3892/mmr.2017.7129].

摘要

在本文发表后,一位关注此事的读者提请编辑注意,图2D和5C中所示的某些细胞周期检测数据与不同作者在其他文章中以不同形式出现的数据惊人地相似。由于上述文章中有争议的数据在提交给[期刊名称]之前已在其他地方发表,或已在考虑发表,编辑决定应从该期刊撤回本文。在与作者联系后,他们同意撤回本文的决定。编辑就由此造成的不便向读者致歉。[原文发表于《分子医学报道》16: 4863 - 4870, 2017;DOI: 10.3892/mmr.2017.7129]

相似文献

1
[Retracted] miR‑663 promotes NPC cell proliferation by directly targeting CDKN2A.
Mol Med Rep. 2022 Jan;25(1). doi: 10.3892/mmr.2021.12539. Epub 2021 Nov 23.
4
6
[Retracted] MicroRNA‑181 serves an oncogenic role in breast cancer via the inhibition of SPRY4.
Mol Med Rep. 2022 May;25(5). doi: 10.3892/mmr.2022.12673. Epub 2022 Mar 10.
8
[Retracted] PAX6, a novel target of miR-335, inhibits cell proliferation and invasion in glioma cells.
Mol Med Rep. 2021 Sep;24(3). doi: 10.3892/mmr.2021.12299. Epub 2021 Jul 19.
9
10
[Retracted] miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6.
Oncol Rep. 2021 Jul;46(1). doi: 10.3892/or.2021.8097. Epub 2021 Jun 3.

引用本文的文献

2
Circular RNAs: characteristics, functions, mechanisms, and potential applications in thyroid cancer.
Clin Transl Oncol. 2024 Apr;26(4):808-824. doi: 10.1007/s12094-023-03324-0. Epub 2023 Oct 21.
3
LncRNA GNAS-AS1 knockdown inhibits keloid cells growth by mediating the miR-188-5p/RUNX2 axis.
Mol Cell Biochem. 2023 Apr;478(4):707-719. doi: 10.1007/s11010-022-04538-6. Epub 2022 Aug 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验